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Abstract; Photocoagulation means coagulation of cells and destruction of 
tissues with the help of excessive brilliant light or laser beam. In the eye, major 
portion of the incident light or laser beam is absorbed m a in ly  by dark melanin 
pigments of retinal pigment epithelium and also by pigments of uveal tissues 
and blood vessels. After absorption, light energy is transformed into thermal 
energy which coagulates the treated tissue. It also occludes small vessels and 
causes contraction of smooth Imuscles and connective tissues. This modality of 
photocoagulation treatment is utilised in ophthalmology in sealing retinal breaks 
by producing chorioretinal adhesion, in coagulating undesired new blood 
vessels, (responsible for retinal haemorrhage and retinopathy, particularly in 
diabetic retinopathy). It is also used for destruction of small Intraocular tumours 
and cysts.
The source of light energy is derieved from specially constructed high pressure 
xenon arc lamp and various types of laser. Argon laser is commonly used for 
treatment of diabetic retinopathy and other retinal disorders and also in treat­
ment of some types of glaucoma.
Neodynium-Yag laser is used mainly for surgical purposes. Krypton laser 
is used specifically for treatment of mascular diseases and CO, laser is used for 
endocoagulation, external surgery and also for treatment of glaucoma.
Keyw ords: Photocoagulation, xenon arc argon laser, krypton laser. Nd-Yag 
laser, diabetic retinopathy.
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I • Introduction
Plato's phaedo contains a passage in which Socrates admonishes that one must 
take care not to look directly at the sun during solar eclipse but to view the sun 
reflection in water. Burning or coagulation effect of solar radiation was known to 
the ancient physicians in India.
Various workers studied the effect of the beam of sun rays to produce a 
burn in the retina. Moran Sales was the first to try photocoagulation (P.C.) in 
experimental animals and human eye but the first publication about clinical photo­
coagulation came in 1948. At that time the light source was a carbon arc named 
Beck Arc, which was not very suitable for its short photocoagulation span and 
producing gases saturated with shoot and carbon particle. In 1956, high pressure 
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xenon lamp was used as the photocoagulation source which is still being used as an 
important modality for P.C.
First optical laser was produced in I960. A  ruby crystal was used to produce 
a 200 sec pulse of intense red light. The ruby laser was effective in producing 
adhesions in the retina and choroid but it was not suitable for treating vascular 
diseases and it is no more in clinical use.
From early 70s argon laser (Blue green), krypton laser and then ND-Yag laser 
were available for clinical use which revolutionised treatment of ocular conditions 
like diabetic retinopathy, veinous occlussions, Eales disease, C.S.R., S.R.N.V., 
capsulotomies with or without I.O.L., membranectomy and some forms of 
glaucoma.
2. Different types of lasers for photocoagulations
Of the various lasers in clinical practice, argon laser is the most commonly and 
widely used. Blue Green Argon laser is absorbed by melanin, haemoglobin and 
xanthophyll pigments. It is not very suitable for treating macular lesions because 
of its absorption by xanthophyll pigments finally damaging nerve fibers. Krypton 
laser is ideal for treating S.R.N.V., because of high absorption by choroid and 
it is excellent for parafoveal coagulation because of no effect on xanthophyll.
Nd-Yag laser is a relatively recent introduction it acts purely by mechanical 
disruption of tissue because of its ability to generate tremendous power within 
extremely short time. It is very useful for producing capsulotomies, iridotomies 
and disruption of vitreous membranes.
2,1. Camparison of modalities of the common lasers for P.C. :
If we compare the two most commonly used modalities for photocoagulation, 
the xenon arc and the lasers : we can note that light from xenon arc source is 
polychromatic contains wave lengths from ultraviolet to infrared inclusive of visible 
spectrum artd suffers from chromatic aberration. It is incoherent and the focal point 
is not as bright as the light source. The energy delivered per unit area is directly 
proportional to the spot size. The spot size being quite large, it is not suitable 
for photocoagulation near fovea. The large infra-red component can lead to 
shrinkage of vitreous and retina. With all its negative points, even today xenon- 
arc photocoagulation is quite efficiently being used for treating nearly all ocular 
conditions requiring P.C. It is preferable in treatment of malignant toumours 
of retina and choroid. It produces full thickness chorio-retinal coagulation and 
useful for treating structural defects in retina.
Light from a laser source is monochromatic, coherent, unidirectional and 
collim at^. It delivers high energy in extremely short periods of time and the 
energy delivered per unit area is inversely proportional to the spot size. It is 
uitable for selective layer coagulation of retina and choroid and for photocoagula­
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tion of macular region. The laser instrument is simple, the light provides a large 
field of view, requires short exposure time and exit light can be manipulated through 
a small pupil.
3. Principle of laser
Now, it would not be out of place to discuss some basic aspects of laser or 
light amplification by stimulated emission of radiation.
All matters radiate electromagnetic radiation. Forty percent of radiation is in 
the visible spectrum between 400 to 700 nanometers. Laseifs can be classified by 
the materials used as the active medium (solid, liquid or gaif) and by their method 
of operation. Atoms, molecules or ions are capable of becoming excited to a 
higher energy state by absorption of thermal, electric or optical energy. The basic 
requirements for any laser are
1. A  suitable medium to be lased ;
2. An external power source ;
3. A  vessel or chamber to contain the medium ;
4. A  focusing system to handle the emission of electromagnetic radiation ;
5. Safety features such as filters for protection.
Argon laser use a gas contained in a glass tube. The gas is energized 
(pumped) by an external source of electric current. When an energized molecule 
is struck by a light beam of appropriate wave length, the stored energy is released 
in the form of an additional beam of light which is of the same wavelength, in 
phase and parallel to the initial beam forming a coherent light. The laser beam is 
allowed to escape into the focusing system and is guided by mirrors and focussed 
by a lens system or directed through a fibre-optic bundle.
3.1. Effects of lasers and their causes ;
A. The thermal effects of laser energy are functions of
(i) Absorption of a particular wavelength ;
(ii) Power density ;
(iii) Duration of exposure ;
(iv) Size of radiated area ;
(v) Cooling component (blood flow).
B. The thermal effects produce 
Controlled thermocoagulation.
Vaporization of tissues.
Coagulation necrosis, 
and oedema.
Lasers in ophthalmology deliver energy either as a continuous wave source or 
as pulsed wave. In continuous wave one watt is delivered for 0.02 sec, the
desired effect.
undesirable effect.
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pulsed laser uses 25 watts at peak power 
120 micro seconds. Perforation of tissue 
short duration.
Spot size (50-700) m/^
Time (0.02-0.2 sec).
Energy (0.1-25 Watts).
Pulses (10-500 Pulses
C.W .
(a) Continuous full power 
Extreme heat build-up
(b) Inefficient energy use 
If cooling is lo s t -  
tube is lost
(c) Central cavity with large ring 
of coagulation necrosis.
and pulsates 6 bursts which lasts 
is accomplished with high energy at a
per second).
P.W.
(a) Full power only as recorded. 
Minimal heat build-up.
(b) Efficient energy use.
If cooling is lo s t -  
no tube damage.
(c) Central cavity with minimal 
tissue damage to surrounding 
area.
3.2. Critical characteristics for precise cutting action of laser :
To achive a mechanical cutting action using light, the light must be in the form 
of a pulse which is short in duration and concentrated in space. Q switching 
concentrates the light into a single smooth pulse from 3 to 20 nano seconds 
(10"“ sec) duration. Mode-locking concentrates the light into a series (or 'train') 
of very short pulse each lasting about 30 picosecond (10“ ®^ second).
A  Q switched laser (nano second) requires more energy than does mode- 
locked laser (picosecond to achieve optical breakdown).
3.3. Short-pulse lasers ;
Short-pulse lasers have recently come into vogue as a non invasive eye surgical 
phototherapy technique. Nd-Yag laser is an infra red beam consisting of photon 
which when focussed, force away electron from molecules, producing plasma and 
shock waves, that in turn rupture the tissues.
4. Clinical aspects of photocoagulation
Now coming back to the clinical aspect the aim of photocoagulation is to maintain 
the macular physiological structure, haemodynamics and fluid dynamics in a 
healthy structure. The alterations that can disturb the macula are
(i) Defective adhesiveness of pigment epithelium to Bruch's membrane.
(ii) Degeneration of the pigment epithelium.
(iii) Vascular defects disturbing nutrient and metabolic transport system.
(iv) Proliferation of neovascular tissue. All these are tackled in different 
ways by photocoagulation either by sealing at the pigment epithelial level or
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knocking out leaking retinal vessels or hypoxic areas or even ablating the normal 
retina in the periphery to save the macula. Photocoagulation can treat permeability 
defects of the retinal vessels. Localised hypoxia of retina and choroid leads to 
production of a biochemical stimulus which promotes neovascularisation. Photo­
coagulation knocks out these hypoxic areas to convert them into atrophic areas so 
that the biochemical stimulus is lost which stops further process of neo­
vascularisation.
4.1. Investigative procedure prior to photocoogulation :
The most important investigate procedure before photocoagulation is fluroescein 
angiography. It reveals (a) abnormalities of retinal blood vessels ; (b) breakdown 
of blood retinal barrier; (c) areas of capillary closure and (d) retinal and 
choroidal tumours.
5. Physical processes in photocoagulation
Thermal reaction induced by photons are called photocoagulation. Protein dena- 
turation by heat produces photocoagulation effect and its ocular reactions are in 
the form of ceil proliferation, migration and scar formation.
Energy levels lower than the coagulation power induce a photochemical or 
thermal reaction, ultraviolet photons induce formation or destruction of chemical 
bonds which produce thermal reactions whereas visible spectrum produces both 
chemical and thermal reaction. Extensive absorption of laser energy can produce 
micro-explosions by raising tissue temperature to the boiling point of water, vasos­
pasms, perivascular changes, obliteration.
Now coming to the diseases treatment by photocoagulation of diabetic 
retinopathy (P.D.R.) heads the list. With better medical treatment the diabetics are 
now enjoying a longer life-span but on the other hand, diabetic retinopathy has 
become the single commonest cause of incurable blindness in the world. Photo­
coagulation is the only sensible treatment for detachment of retina. Previously 
main thrust was in treating the neovascular areas directly, but the reports of 
detachment of retina surgery group in U .S .A ., clearly established the usefulness of 
the indirect approach in the form of pan-retinal photocoagulation (P.R.P.). Cases of 
advanced background diabetic retinopathy, P.D.R. and cases of maculopathy are 
selected for photocoagulation. Some cases of maculopathy which also require 
focal photocoagulation for which krypton laser will be the best.
6. Photocoagulation retinal therapy
In P.R.P. the retina from nasal to the disc and outside the temporal arcade is destroyed 
upto or beyond the equator. P.R.P. achieves its target of improved oxygen perfusion 
of macula and reducing vasoproliferative factors by varying combination of 
factors e.g.
(i) Reduction or elimination of the areas of retinal hypoxia ;
(ii) Greater perfusion from the choroidal circulation by achieving a closer 
approximation of the inner layers of the retina with choriocapiUaries ;
(iii) Diverting the available blood to the central area ;
(iv) Destruction of leaking blood vessels and normalising the vascular supply 
of the macula. P.R P. can be performed by xenon arc, argon laser or krypton laser. 
One thing is certain that P.R.P. is destroying a bulk of retina-unhealthy and healthy. 
Diabetic retinopathy manifestations are also destroying the retina and some 
may think that both processes are competitors for destroying the retina. The
difference being that when we are destroying the retina we preserve the most useful 
central area but the disease is not selective. It is like carrying your own bomb for 
preventing the other bomb from exploding.
P.R.P. is contra-indicated in eyes with extensive glial proliferation or vitreore- 
tinal traction, florid surface neovascularisation and in the presence of massive 
oedema and exudates with or without associated hypertensive retinopathy.
P.R.P. V7ith argon laser will require 2000 to 3000 spots of 250 to 500 microns 
size set at 0.1 to 0.2 sec and 250 to 600 millwatts. P.R.P. is also indicated in cases 
of central retinal vein occlusion and some cases of B.R.V.O. In C.R.V.O. it prevent 
neovascular glaucoma and micro cystic changes in the macula. Some cases of 
advanced Bale's disease may require P .R.P. but most cases of Bale's disease will 
require sector coagulation.
Photocoagulation is a safe and effective way of treating retinal breaks where 
the retina is not detached. It is very useful in cases of operated retinal detachment 
and may prevent much troublesome re-operation.
Intraocular tumours like retinoblastoma, malignant melanoma etc. are often 
treated with photocoagulation. Here xenon arc is preferred to the laser photo­
coagulators.
Photocoagulation near fovea is required in cases of S.R.N.V. and C.S.R. 
Recently, some workers have observed that the treated and untreated cases of C.S.R. 
behave in the same way in the long run.
Though not coming in the group of photocoagulation, lasers are presently being 
employed in treatment of various glaucomas. Laser iridotomy for angle closure 
glaucoma and laser trabeculoplasty for open angle glaucoma are the commonly 
practised procedures.
Nd-Yag laser capsulotomy (with or without I.O .L.), membranectomy etc. has 
already been discussed.
Users have been found useful in treating various anterior segment pathology 
lite coagulation of iris tumours, iris cysts, occuluding vessels in rubeosis iridis, 
corneal vascularisation and producing photomydriasis or fashioning of new pupil.
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7. Limitation of photocoagulation
The dark part of photocoagulation is that it does not cure the disease but in best 
cases can stabilise the cause and minimise further deterioration. The treatment 
modality like any other modality is not immuned from side-effects, complications 
and has some limitations too.
The limitations may come from several factors e.g.,
(i) No more healthy tissue available for photocoagulation ;
(ii) Retinopathy rise factors ;
(iii) Extensive glial proliferation and vitreo-ietinal traction ;
(iv) Hypertensive retinopathy renal feature.
Relative limitation may crop up from factors like
(a) Bed-ridden and non cooperative patient;
(b) Small palpebral fissure ;
(c) Small immobile pupil ;
(d) Hazy media-cornea, lens and vitreous ;
(e) Tractional retinal detachment.
Side effects of photocoagulation are
(i) Temporary reduction of vision ;
(ii) Myopia ;
(iii) Mild iritis ;
(iv) Changes in dark adaptation ;
(v) Colour perception alteration ;
(vi) Field defect;
(vii) Changes in pupil ;
(viil) R iseofl.O .P .
Other complications are
(a) Macular oedema ;
(b ) Localised bleeding ;
(c) Foveolar burn ;
(d ) Traction retinal detachment.
8. Future developments in lasers for photocoagulation
The future prospects are so bright that in future we may get a new branch called 
'Photosurgery' which will be labelled as "all surgery done in contact or non-contact 
way with the help of photons," on the other hand the gloomy aspect can be realised 
from the increasing trend of compensation and medical insurance in Western 
countries.
8.1 Some salient features of recent lasers are listed below
(i) Dye lasers: Wavelertgth is tunable from 488 to 680 nanometers by 
changing tha dye. Tha wave length can be adapted to the structure to be treated.
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(ii) Excimer lasers: This is also tunable laser basically used for photo- 
ablative purpose. Radial keratotomy and keratoconous correction could be possible.
(iii) C O 2 lasers; The wavelength of 10.6 nm makes it useful for extrabulbar 
applications like removal of tumour, opening of sclera for drainage of S.R.F.
(iv) Erbium lasers: Wavelength of 1.5 nm makes it suitable for capsulotomy 
without penetration of radiation into the vitreous.
(v) Semiconductor lasers ; This operation in new infra-red may make them 
suitable for photo-acupuncture, photo-anaesthesia etc.
9. Conclusions
With all these modalities, we are only trying to cure the signs and symptoms and 
not the course to which is added the problem of over-treating or over photo- 
coagulating.
If we are able to change the cellular contents or activity and could create a 
molecular rejuvenation, than we will be able to transform the diseased cell (cornea 
or retina) into healthy ones (young ones) and the cause may be cured.
The care for over-treating or over-photocoagulation would be the use of a 
computer system that has an autodose program for the various disease.
We can speculate that within next 10 to 20 years, the operation theatre w ill 
be filled with robots that will reduce our task to watch a real time image 
analysis system and the superior human brain solving the problems more efficiently.
